Successful treatment of patients with HCV GT3 infection and cirrhosis with elbasvir/grazoprevir plus sofosbuvir does not correct insulin resistance by 12 weeks post-treatment

G Foster; K Agarwal; ME Cramp; S Moreea; S Barclay; J Collier; AS Brown; SD Ryder; A Ustianowski; DM Forton; R Fox; F Gordon; WM Rosenberg; DJ Mutimer; J Du; CL Gilbert; M Robertson; E Barr; B Haber

doi:10.1016/s0168-8278(17)31409-5

Successful treatment of patients with HCV GT3 infection and cirrhosis with elbasvir/grazoprevir plus sofosbuvir does not correct insulin resistance by 12 weeks post-treatment

G Foster
, K Agarwal
, ME Cramp
, S Moreea
, S Barclay
, J Collier
, AS Brown
, SD Ryder
, A Ustianowski
, DM Forton
, R Fox
, F Gordon
, WM Rosenberg
, DJ Mutimer
, J Du
, CL Gilbert
, M Robertson
, E Barr
, B Haber

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
DOIs	https://doi.org/10.1016/s0168-8278(17)31409-5
Publication status	Published - Apr 2017

Access to Document

10.1016/s0168-8278(17)31409-5

Cite this

Foster, G., Agarwal, K., Cramp, ME., Moreea, S., Barclay, S., Collier, J., Brown, AS., Ryder, SD., Ustianowski, A., Forton, DM., Fox, R., Gordon, F., Rosenberg, WM., Mutimer, DJ., Du, J., Gilbert, CL., Robertson, M., Barr, E., & Haber, B. (2017). Successful treatment of patients with HCV GT3 infection and cirrhosis with elbasvir/grazoprevir plus sofosbuvir does not correct insulin resistance by 12 weeks post-treatment. https://doi.org/10.1016/s0168-8278(17)31409-5

@conference{eb9c73a6427d4edf921b2ea363c4ac31,

title = "Successful treatment of patients with HCV GT3 infection and cirrhosis with elbasvir/grazoprevir plus sofosbuvir does not correct insulin resistance by 12 weeks post-treatment",

author = "G Foster and K Agarwal and ME Cramp and S Moreea and S Barclay and J Collier and AS Brown and SD Ryder and A Ustianowski and DM Forton and R Fox and F Gordon and WM Rosenberg and DJ Mutimer and J Du and CL Gilbert and M Robertson and E Barr and B Haber",

year = "2017",

month = apr,

doi = "10.1016/s0168-8278(17)31409-5",

language = "English",

}

Foster, G, Agarwal, K, Cramp, ME, Moreea, S, Barclay, S, Collier, J, Brown, AS, Ryder, SD, Ustianowski, A, Forton, DM, Fox, R, Gordon, F, Rosenberg, WM, Mutimer, DJ, Du, J, Gilbert, CL, Robertson, M, Barr, E & Haber, B 2017, 'Successful treatment of patients with HCV GT3 infection and cirrhosis with elbasvir/grazoprevir plus sofosbuvir does not correct insulin resistance by 12 weeks post-treatment'. https://doi.org/10.1016/s0168-8278(17)31409-5

TY - CONF

T1 - Successful treatment of patients with HCV GT3 infection and cirrhosis with elbasvir/grazoprevir plus sofosbuvir does not correct insulin resistance by 12 weeks post-treatment

AU - Foster, G

AU - Agarwal, K

AU - Cramp, ME

AU - Moreea, S

AU - Barclay, S

AU - Collier, J

AU - Brown, AS

AU - Ryder, SD

AU - Ustianowski, A

AU - Forton, DM

AU - Fox, R

AU - Gordon, F

AU - Rosenberg, WM

AU - Mutimer, DJ

AU - Du, J

AU - Gilbert, CL

AU - Robertson, M

AU - Barr, E

AU - Haber, B

PY - 2017/4

Y1 - 2017/4

U2 - 10.1016/s0168-8278(17)31409-5

DO - 10.1016/s0168-8278(17)31409-5

M3 - Conference paper (not formally published)

ER -